Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/57092
Title: How bilastine is used to treat allergic rhinitis and urticaria in children.
Authors: 
Keywords: 
Mesh: 
Issue Date: 1-Dec-2021
Citation: Immunotherapy.2022;(14)1:77-89
Abstract: Management guidelines for allergic rhinitis and urticaria recommend oral second-generation antihistamines as first-line treatment. The efficacy and safety of bilastine, the newest nonsedating second-generation antihistamine, are well established in adolescents/adults with these allergic conditions. The bilastine development program for pediatric use (2-
PMID: 34850647
URI: https://hdl.handle.net/20.500.12530/57092
Appears in Collections:Fundaciones e Institutos de Investigación > FIB H. Infantil U. Niño Jesús > Artículos

Files in This Item:
The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.